Cargando…

Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis

OBJECTIVE: The mechanism of Panax notoginseng in treating myocardial fibrosis (MF) was investigated using network pharmacology. METHODS: Effective ingredients and potential targets of Panax notoginseng were screened in relevant databases to construct a compound-target network. Targets of MF were the...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jingxue, Hou, Jingyi, Liu, Yu, Liu, Peng, Zhao, Tingting, Wang, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975676/
https://www.ncbi.nlm.nih.gov/pubmed/35372585
http://dx.doi.org/10.1155/2022/8895950
_version_ 1784680416290013184
author Han, Jingxue
Hou, Jingyi
Liu, Yu
Liu, Peng
Zhao, Tingting
Wang, Xinwei
author_facet Han, Jingxue
Hou, Jingyi
Liu, Yu
Liu, Peng
Zhao, Tingting
Wang, Xinwei
author_sort Han, Jingxue
collection PubMed
description OBJECTIVE: The mechanism of Panax notoginseng in treating myocardial fibrosis (MF) was investigated using network pharmacology. METHODS: Effective ingredients and potential targets of Panax notoginseng were screened in relevant databases to construct a compound-target network. Targets of MF were then screened to select common targets and construct a protein-protein interaction network. This was followed by Gene Ontology and pathway enrichment analyses. Molecular docking then verified the results of network analysis. RESULTS: A total of 14 effective ingredients and 119 potential targets for MF were predicted. Quercetin, beta-sitosterol, and gossypetin were speculated to be the main active ingredients. The mechanism of action may be related to AGE-RAGE, proteoglycans, and IL-17 signaling pathways. Five key targets (IL6, ALB, AKT1, TNF, and VEGFA) may be involved in the treatment of MF using Panax notoginseng. CONCLUSIONS: This study embodies the complex network relationship of multicomponents, multitargets, and multipathways of Panax notoginseng in treating MF and provides a novel method for further research on this herb's mechanism.
format Online
Article
Text
id pubmed-8975676
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-89756762022-04-02 Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis Han, Jingxue Hou, Jingyi Liu, Yu Liu, Peng Zhao, Tingting Wang, Xinwei J Diabetes Res Research Article OBJECTIVE: The mechanism of Panax notoginseng in treating myocardial fibrosis (MF) was investigated using network pharmacology. METHODS: Effective ingredients and potential targets of Panax notoginseng were screened in relevant databases to construct a compound-target network. Targets of MF were then screened to select common targets and construct a protein-protein interaction network. This was followed by Gene Ontology and pathway enrichment analyses. Molecular docking then verified the results of network analysis. RESULTS: A total of 14 effective ingredients and 119 potential targets for MF were predicted. Quercetin, beta-sitosterol, and gossypetin were speculated to be the main active ingredients. The mechanism of action may be related to AGE-RAGE, proteoglycans, and IL-17 signaling pathways. Five key targets (IL6, ALB, AKT1, TNF, and VEGFA) may be involved in the treatment of MF using Panax notoginseng. CONCLUSIONS: This study embodies the complex network relationship of multicomponents, multitargets, and multipathways of Panax notoginseng in treating MF and provides a novel method for further research on this herb's mechanism. Hindawi 2022-03-25 /pmc/articles/PMC8975676/ /pubmed/35372585 http://dx.doi.org/10.1155/2022/8895950 Text en Copyright © 2022 Jingxue Han et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Han, Jingxue
Hou, Jingyi
Liu, Yu
Liu, Peng
Zhao, Tingting
Wang, Xinwei
Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis
title Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis
title_full Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis
title_fullStr Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis
title_full_unstemmed Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis
title_short Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis
title_sort using network pharmacology to explore the mechanism of panax notoginseng in the treatment of myocardial fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975676/
https://www.ncbi.nlm.nih.gov/pubmed/35372585
http://dx.doi.org/10.1155/2022/8895950
work_keys_str_mv AT hanjingxue usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis
AT houjingyi usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis
AT liuyu usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis
AT liupeng usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis
AT zhaotingting usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis
AT wangxinwei usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis